Tessa Mauldin, APRN
Adult Health · Tyler, TXNPI 1851814172
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (49.6%), food and beverage and education — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by ZOLL Respicardia, Inc. at 52.4% of the total. 2025 is the largest year on record at $2,931, 9.8 times the $299 reported in 2022. Among adult health clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 69 payments — averaging $92.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Respicardia, Inc.$3K
- Inspire Medical Systems, Inc.$2K
- Harmony Biosciences LLC$370
- Jazz Pharmaceuticals Inc.$235
- Axsome Therapeutics, Inc.$121
- Merck$74
- plus $73 from 2 others
What the payments were for
- Travel & lodging$3,16550%
- Food & beverage$3,02047%
- Education$1953%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Respicardia, Inc. | 16 | $3,346 |
| Inspire Medical Systems, Inc. | 18 | $2,162 |
| Harmony Biosciences LLC | 16 | $370 |
| Jazz Pharmaceuticals Inc. | 7 | $235 |
| Axsome Therapeutics, Inc. | 5 | $121 |
| Merck | 3 | $74 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $54 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- remede System$3,059
- Inspire$1,670
- XYWAV$113
How this compares
$6,380 in reported general payments places this provider in the 90th percentile of 933 adult health providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Zolpidem Tartrate ErZolpidem Tartrate | 16 | $795 |
| Modafinil | 16 | $706 |
| Doxepin Hcl | 54 | $656 |
| Zolpidem Tartrate | 65 | $410 |
| Trazodone Hcl | 84 | $311 |
| Quetiapine Fumarate | 15 | $306 |
| Gabapentin | 27 | $253 |
| Temazepam | 12 | $150 |
| Clonazepam | 25 | $114 |
Paid to pharmacies, not to this prescriber.
Other adult health in Tyler
- Misty SheddAllen$863K
- Melodie YoungDallas$700K
- Cynthia BedellPlano$168K
- Elizabeth Wedberg SivamAustin$71K
- Mary SalazarSan Antonio$68K
- Eric KlappholzDallas$44K
- Christin TouchetKingwood$43K
- Yulia LyuboslavskyAustin$36K
- Meghan MurphyAustin$29K
- Sandra CareyGrapevine$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.